Mylan executives refuse to testify at Senate hearing on EpiPen price
November 22, 2016 at 02:56 AM EST
Stephen Feller WASHINGTON, Nov. 22 (UPI) -- Representatives for Mylan, the company that makes EpiPens, will not appear at a Senate hearing about overcharging Medicaid for years and settling the charges.
